EMG
ALDR

Ellington Management Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Ellington Management Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,200
Closed -$142K – 998
2018
Q1 		$142K Buy
+11,200
New +$162K 0.01% 765
2017
Q4 		– Sell
-17,700
Closed -$217K – 909
2017
Q3 		$217K Buy
+17,700
New +$185K 0.04% 502
2015
Q3 		– Sell
-7,610
Closed -$403K – 980
2015
Q2 		$403K Buy
+7,610
New +$277K 0.1% 319
2015
Q1 		– Sell
-15,200
Closed -$442K – 884
2014
Q4 		$442K Buy
+15,200
New +$273K 0.15% 232

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return